Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01987349 · ClinicalTrials.gov registry record · Phase 4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009
A Phase 4 study of Influenza, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT01987349: Completed Phase 4 study of Influenza, sponsored by Stanford University.
NCT01987349 is a Phase 4 study of Influenza that has completed, run by Stanford University. The registered enrollment target is 72 participants, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01987349, a Phase 4 study of Influenza, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare influenza vaccine responses in monozygotic and dizygotic twins.
Conditions Studied
Interventions
- BIOLOGICAL Fluzone® (intramuscular)
- BIOLOGICAL FluMist® (intranasal)
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
What the finished NCT01987349 record still lists
NCT01987349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which Fluzone® (intramuscular) is the first listed.
NCT01987349 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01987349 about?
NCT01987349 is a clinical study titled "T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009". This study will compare influenza vaccine responses in monozygotic and dizygotic twins.
What is the current status of trial NCT01987349?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2009-09. Estimated completion is 2010-01.
What conditions does trial NCT01987349 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT01987349?
The interventions under investigation include: Fluzone® (intramuscular) (BIOLOGICAL), FluMist® (intranasal) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01987349?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01987349 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01987349's enrollment target sits among peer trials
72 115th of 156 higher than 42 of 156 other Influenza trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
RECRUITING · Phase 4
-
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
RECRUITING · Phase 4
-
Bone Marrow and Peripheral Blood Immune Responses Study
RECRUITING · Phase 4
-
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine
COMPLETED · Phase 4
-
A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age
COMPLETED · Phase 4
-
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia